Axon Enterprise (NASDAQ:AXON) CEO Sells $7,137,400.00 in Stock

Axon Enterprise, Inc (NASDAQ:AXONGet Free Report) CEO Patrick Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the sale, the chief executive officer owned 3,033,982 shares in the company, valued at approximately $2,165,474,312.68. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Axon Enterprise Stock Down 4.2%

Axon Enterprise stock opened at $703.03 on Friday. Axon Enterprise, Inc has a 1-year low of $422.38 and a 1-year high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock has a market cap of $55.19 billion, a PE ratio of 173.59, a P/E/G ratio of 28.50 and a beta of 1.41. The stock’s fifty day moving average is $755.57 and its two-hundred day moving average is $712.63.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. During the same period last year, the firm earned $1.20 earnings per share. Axon Enterprise’s quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

A number of institutional investors have recently added to or reduced their stakes in AXON. TCTC Holdings LLC boosted its holdings in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its holdings in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after purchasing an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the 1st quarter valued at approximately $31,000. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter valued at approximately $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in Axon Enterprise in the 1st quarter valued at approximately $33,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a report on Wednesday, September 24th. Wolfe Research initiated coverage on Axon Enterprise in a report on Monday, July 7th. They set an “outperform” rating on the stock. Raymond James Financial reaffirmed an “outperform” rating and set a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Piper Sandler initiated coverage on Axon Enterprise in a report on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price objective on the stock. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Axon Enterprise in a report on Wednesday. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $841.64.

View Our Latest Stock Report on Axon Enterprise

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Insider Buying and Selling by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.